title: Diabetes Accelerates Retinal Neuronal Cell Death In A Mouse Model of Endogenous Hyperhomocysteinemia.
abstract: Hyperhomocysteinemia has been implicated in visual dysfunction. We reported recently that mice with endogenous hyperhomocysteinemia, due to mutation of the cystathionine-β-synthase (cbs) gene, demonstrate loss of neurons in the retinal ganglion cell (RGC) layer and other retinal layers as homocysteine levels increase. Some clinical studies implicate hyperhomocysteinemia in the pathogenesis of diabetic retinopathy, which is also characterized by RGC loss. The present study used cbs(+/-) mice to determine whether modest elevation of plasma homocysteine, in the presence of diabetes, accelerates neuronal cell loss. Diabetes (DB) was induced in 3 wk old cbs(+/-) and wildtype mice using streptozotocin; four groups of mice were studied: DB cbs(+/-); non-DB cbs(+/-); DB cbs(+/+); non-DB cbs(+/+). One group of diabetic cbs(+/-) mice was maintained on a high methionine diet (HMD, 0.5% methionine drinking water) to increase plasma homocysteine slightly. Eyes were harvested at 5, 10 and 15 weeks post-onset of diabetes; retinal cryosections were examined by light microscopy and subjected to systematic morphometric analysis. Diabetic cbs(+/-) had significantly fewer RGCs at 5 weeks compared to age-matched, non-diabetic cbs(+/-) and wildtype controls (10.0 ± 0.5 versus 14.9 ± 0.5 and 15.8 ± 0.6 cells/100 µm retina length, respectively). Significant differences in retinas of DB/high homocysteine versus controls were obtained 15 wks post-onset of diabetes including fewer RGCS and decreased thickness of inner nuclear and plexiform layers. Moderate increases in plasma homocysteine coupled with diabetes cause a more dramatic alteration of retinal phenotype than elevated homocysteine or diabetes alone and suggest that diabetes accelerates the retinal neuronal death in hyperhomocysteinemic mice.
authors.affiliation: Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, Georgia.
authors.forename: Preethi S
authors.initials: PS
authors.lastname: Ganapathy
authors.forename: Penny
authors.initials: P
authors.lastname: Roon
authors.forename: Tracy K V E
authors.initials: TK
authors.lastname: Moister
authors.forename: Barbara
authors.initials: B
authors.lastname: Mysona
authors.forename: Sylvia B
authors.initials: SB
authors.lastname: Smith
references.citation: Circ Res. 2001 Jun 8;88(11):1203-9
references.pmid: 11397788
references.citation: Eye (Lond). 2008 Aug;22(8):989-93
references.pmid: 18064053
references.citation: J Neural Transm (Vienna). 2002 Dec;109(12):1499-504
references.pmid: 12486490
references.citation: Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):66-75
references.pmid: 15046867
references.citation: Exp Eye Res. 2001 Jul;73(1):45-57
references.pmid: 11428862
references.citation: Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3330-6
references.pmid: 15326158
references.citation: Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1596-605
references.pmid: 18556571
references.citation: Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):497-500
references.pmid: 15931548
references.citation: Am J Clin Nutr. 2002 Oct;76(4):897-902
references.pmid: 12324306
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):283-90
references.pmid: 12657367
references.citation: Zhonghua Nei Ke Za Zhi. 2002 Jan;41(1):34-8
references.pmid: 11940295
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1585-9
references.pmid: 7878023
references.citation: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4460-70
references.pmid: 19357353
references.citation: Arch Ophthalmol. 2005 Aug;123(8):1143-6
references.pmid: 16087854
references.citation: Eur J Ophthalmol. 2008 Mar-Apr;18(2):226-32
references.pmid: 18320515
references.citation: Retina. 2008 May;28(5):741-3
references.pmid: 18463519
references.citation: J Intern Med. 2005 Nov;258(5):450-9
references.pmid: 16238681
references.citation: Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4785-94
references.pmid: 17898305
references.citation: Diabetes. 2006 Sep;55(9):2401-11
references.pmid: 16936187
references.citation: Am J Ophthalmol. 2006 Jan;141(1):201-3
references.pmid: 16387004
references.citation: J Neural Transm (Vienna). 2007;114(5):571-5
references.pmid: 17238009
references.citation: Am J Ophthalmol. 2004 Jan;137(1):84-9
references.pmid: 14700648
references.citation: Am J Clin Nutr. 2000 Feb;71(2):614S-620S
references.pmid: 10681269
references.citation: Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3607-12
references.pmid: 19369240
references.citation: Diabetes. 1997 May;46(5):887-94
references.pmid: 9133560
references.citation: J Neurochem. 2008 Sep;106(5):1977-90
references.pmid: 18466320
references.citation: Cell Death Differ. 2004 Jul;11 Suppl 1:S56-64
references.pmid: 15243582
references.citation: Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3143-50
references.pmid: 16799061
references.citation: J Neural Transm (Vienna). 2007;114(4):445-50
references.pmid: 16932990
references.citation: Trends Neurosci. 2003 Mar;26(3):137-46
references.pmid: 12591216
references.citation: Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):66-73
references.pmid: 17027242
references.citation: Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2210-8
references.pmid: 15914643
references.citation: Diabetes Care. 2008 Jan;31(1):50-6
references.pmid: 17898092
references.citation: J Glaucoma. 2007 Mar;16(2):234-9
references.pmid: 17473737
references.citation: Diab Vasc Dis Res. 2007 Jun;4(2):143-50
references.pmid: 17654449
references.citation: Clin Chim Acta. 2002 Dec;326(1-2):105-12
references.pmid: 12417101
references.citation: Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4154-61
references.pmid: 18469181